165 related articles for article (PubMed ID: 19232088)
1. Comparison of injecting drug users who obtain syringes from pharmacies and syringe exchange programs in Tallinn, Estonia.
Vorobjov S; Uusküla A; Abel-Ollo K; Talu A; Rüütel K; Des Jarlais DC
Harm Reduct J; 2009 Feb; 6():3. PubMed ID: 19232088
[TBL] [Abstract][Full Text] [Related]
2. Should pharmacists have a role in harm reduction services for IDUs? A qualitative study in Tallinn, Estonia.
Vorobjov S; Uusküla A; Abel-Ollo K; Talu A; Jarlais DD
J Urban Health; 2009 Nov; 86(6):918-28. PubMed ID: 19921542
[TBL] [Abstract][Full Text] [Related]
3. Greater drug injecting risk for HIV, HBV, and HCV infection in a city where syringe exchange and pharmacy syringe distribution are illegal.
Neaigus A; Zhao M; Gyarmathy VA; Cisek L; Friedman SR; Baxter RC
J Urban Health; 2008 May; 85(3):309-22. PubMed ID: 18340537
[TBL] [Abstract][Full Text] [Related]
4. Comparison of injection drug users accessing syringes from pharmacies, syringe exchange programs, and other syringe sources to inform targeted HIV prevention and intervention strategies.
Rudolph AE; Crawford ND; Ompad DC; Benjamin EO; Stern RJ; Fuller CM
J Am Pharm Assoc (2003); 2010 Mar-Apr 1; 50(2):140-7. PubMed ID: 20199954
[TBL] [Abstract][Full Text] [Related]
5. Syringe acquisition experiences and attitudes among injection drug users undergoing short-term opioid detoxification in Massachusetts and Rhode Island.
Zaller ND; Yokell MA; Nayak SM; Fu JJ; Bazazi AR; Rich JD
J Urban Health; 2012 Aug; 89(4):659-70. PubMed ID: 22427232
[TBL] [Abstract][Full Text] [Related]
6. Access to sterile syringes through San Francisco pharmacies and the association with HIV risk behavior among injection drug users.
Riley ED; Kral AH; Stopka TJ; Garfein RS; Reuckhaus P; Bluthenthal RN
J Urban Health; 2010 Jul; 87(4):534-42. PubMed ID: 20526690
[TBL] [Abstract][Full Text] [Related]
7. Racial differences in acquisition of syringes from pharmacies under conditions of legal but restricted sales.
Costenbader EC; Zule WA; Coomes CC
Int J Drug Policy; 2010 Sep; 21(5):425-8. PubMed ID: 20097052
[TBL] [Abstract][Full Text] [Related]
8. Expanded syringe exchange programs and reduced HIV infection among new injection drug users in Tallinn, Estonia.
Uusküla A; Des Jarlais DC; Kals M; Rüütel K; Abel-Ollo K; Talu A; Sobolev I
BMC Public Health; 2011 Jun; 11():517. PubMed ID: 21718469
[TBL] [Abstract][Full Text] [Related]
9. Syringe source, use, and discard among injection-drug users in New Haven, Connecticut.
Khoshnood K; Blankenship KM; Pollack HA; Roan CT; Altice FL
AIDS Public Policy J; 2000; 15(3-4):88-94. PubMed ID: 12189714
[TBL] [Abstract][Full Text] [Related]
10. Sterile syringe access conditions and variations in HIV risk among drug injectors in three cities.
Bluthenthal RN; Malik MR; Grau LE; Singer M; Marshall P; Heimer R;
Addiction; 2004 Sep; 99(9):1136-46. PubMed ID: 15317634
[TBL] [Abstract][Full Text] [Related]
11. Commentary on Vorobjov et al., "Comparison of injection drug users who obtain syringes from pharmacies and syringe exchange programs in Tallinn, Estonia".
Werb D; Wood E
Harm Reduct J; 2009 Nov; 6():33. PubMed ID: 19943944
[TBL] [Abstract][Full Text] [Related]
12. Syringe laws and pharmacy regulations are structural constraints on HIV prevention in the US.
Taussig JA; Weinstein B; Burris S; Jones TS
AIDS; 2000 Jun; 14 Suppl 1():S47-51. PubMed ID: 10981474
[TBL] [Abstract][Full Text] [Related]
13. HIV infection and risk, prevention, and testing behaviors among injecting drug users -- National HIV Behavioral Surveillance System, 20 U.S. cities, 2009.
Broz D; Wejnert C; Pham HT; DiNenno E; Heffelfinger JD; Cribbin M; Krishna N; Teshale EH; Paz-Bailey G;
MMWR Surveill Summ; 2014 Jul; 63(6):1-51. PubMed ID: 24990587
[TBL] [Abstract][Full Text] [Related]
14. Impact of pharmacy-based syringe access on injection practices among injecting drug users in Minnesota, 1998 to 1999.
Cotten-Oldenburg NU; Carr P; DeBoer JM; Collison EK; Novotny G
J Acquir Immune Defic Syndr; 2001 Jun; 27(2):183-92. PubMed ID: 11404541
[TBL] [Abstract][Full Text] [Related]
15. Pharmacy access to syringes among injecting drug users: follow-up findings from Hartford, Connecticut.
Singer M; Baer HA; Scott G; Horowitz S; Weinstein B
Public Health Rep; 1998 Jun; 113 Suppl 1(Suppl 1):81-9. PubMed ID: 9722813
[TBL] [Abstract][Full Text] [Related]
16. Multiple access to sterile syringes for injection drug users: vending machines, needle exchange programs and legal pharmacy sales in Marseille, France.
Moatti JP; Vlahov D; Feroni I; Perrin V; Obadia Y
Eur Addict Res; 2001 Mar; 7(1):40-5. PubMed ID: 11316925
[TBL] [Abstract][Full Text] [Related]
17. HCV serostatus and injection sharing practices among those who obtain syringes from pharmacies and directly and indirectly from syringe services programs in rural New England.
Romo E; Rudolph AE; Stopka TJ; Wang B; Jesdale BM; Friedmann PD
Addict Sci Clin Pract; 2023 Jan; 18(1):2. PubMed ID: 36597153
[TBL] [Abstract][Full Text] [Related]
18. Pharmacist and pharmacy staff experiences with non-prescription (NP) sale of syringes and attitudes toward providing HIV prevention services for injection drug users (IDUs) in Providence, RI.
Zaller N; Jeronimo A; Bratberg J; Case P; Rich JD
J Urban Health; 2010 Dec; 87(6):942-53. PubMed ID: 21116724
[TBL] [Abstract][Full Text] [Related]
19. The impact of legalizing syringe exchange programs on arrests among injection drug users in California.
Martinez AN; Bluthenthal RN; Lorvick J; Anderson R; Flynn N; Kral AH
J Urban Health; 2007 May; 84(3):423-35. PubMed ID: 17265133
[TBL] [Abstract][Full Text] [Related]
20. A longitudinal study of syringe acquisition by Puerto Rican injection drug users in New York and Puerto Rico: implications for syringe exchange and distribution programs.
Finlinson HA; Oliver-Vélez D; Deren S; Cant JG; Colón HM; Robles RR; Kang SY; Andía JF
Subst Use Misuse; 2006; 41(9):1313-36. PubMed ID: 16861181
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
